Jpmorgan Chase & CO Twist Bioscience Corp Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Twist Bioscience Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,799,212 shares of TWST stock, worth $84.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,799,212
Previous 2,475,273
27.31%
Holding current value
$84.3 Million
Previous $112 Million
25.24%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding TWST
# of Institutions
264Shares Held
67.7MCall Options Held
136KPut Options Held
48.1K-
Artisan Partners Limited Partnership Milwaukee, WI5.89MShares$276 Million0.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$272 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.6MShares$262 Million2.28% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$254 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.58MShares$168 Million0.03% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.64B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...